COVID-19 vaccine is effective in inflammatory bowel disease patients and is not associated with disease exacerbation

Studies have shown decreased response to COVID-19 vaccinations in some populations. In addition, it is possible that vaccine-triggered immune activation could trigger immune-dysregulation and thus exacerbate inflammatory bowel diseases (IBD). In this population-based study we used the epi-Israeli IBD Research Nucleus (IIRN) validated cohort to explore the effectiveness of COVID-19 vaccination in IBD and to assess its effect on disease outcomes.

Source: Clinical Gastroenterology and Hepatology - December 23, 2021 Category: Gastroenterology Authors: Raffi Lev-Tzion, Gili Focht, Rona Lujan, Adi Mendelovici, Chagit Friss, Shira Greenfeld, Revital Kariv, Amir Ben-Tov, Eran Matz, Daniel Nevo, Yuval Barak-Corren, Iris Dotan, Dan Turner Source Type: research